Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates: Surgical Results From CALGB 40603 (Alliance)

OBJECTIVE: To assess the efficacy of neoadjuvant systemic therapy (NST) at increasing the rate of successful breast-conserving therapy (BCT) in triple negative breast cancer. BACKGROUND: Inducing tumor regression to permit BCT is often cited to support administration of NST. To quantify this benefit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg
Main Authors: Golshan, Mehra, Cirrincione, Constance T., Sikov, William M., Berry, Donald A., Jasinski, Sara, Weisberg, Tracey F., Somlo, George, Hudis, Clifford, Winer, Eric, Ollila, David W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710511/
https://ncbi.nlm.nih.gov/pubmed/26222764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000001417
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados